.avif){kind=spacer}
From being featured in Health Innovation Leeds’ Business in the Spotlight series, to hosting a ministerial roundtable and lab visit at Nexus, and representing the UK on Innovate UK’s Global Business Innovation Programme (GBIP) to Singapore, the past few weeks have reinforced both the strength of the Leeds ecosystem and the global relevance of our work.
We were proud to be the focus of Health Innovation Leeds’ recent Business in the Spotlight feature, which highlighted the vision behind MNS and the potential impact of our Miarcus™ platform on how vaccines and medicines are delivered.
The piece explored our journey from an academic concept at the University of Leeds to agrowing medtech company based at Nexus, and the way Miarcus™ aims to remove long-standing barriers to access:
You can read the full feature on the Health Innovation Leeds website: “Business in the Spotlight – Microneedle Solutions” (healthinnovationleeds.com).
That theme of “Leeds as a health innovation hub” came into sharp focus when MNS hosted a ministerial roundtable and lab visit at Nexus with a cross-party delegation from the UK Parliament.
The delegation, part of the Business and Trade Committee’s work, included:
The visit brought together parliamentarians, regional leaders and innovators to discuss both the opportunities and the real-world challenges faced by medtech companies operating in the North of England.
At the roundtable and during the subsequent lab tour, we were able to:
For MNS, it was a valuable opportunity to ensure that the lived experience of building and testing new health technologies in Leeds is reflected directly in national policy conversations.
Shortly after the ministerial visit, MNS was honoured to be selected as part of Innovate UK’s Global Business Innovation Programme (GBIP) delegation to Singapore.
Alongside a fantastic cohort of UK medtech and healthtech companies, we spent an intensive week:
The mission underlined just how globally relevant the challenges we are working on really are – from workforce pressures and infrastructure constraints to vaccine hesitancy and health inequalities. It also opened up a number of promising conversations about future collaboration in the region.
Taken together, the Health Innovation Leeds spotlight, the ministerial roundtable and lab visit, and the GBIP mission to Singapore tell a coherent story:
MNS is committed to playing our part in that story. Over the coming months we will continue to:
Our mission remains clear: to reduce health inequalities across the globe by increasing access to medication, irrespective of location, race or gender – starting with a microneedle patch developed in Leeds and designed for the world.